| Name | Duvelisib (IPI-145, INK1197) | CAS# | 1201438-56-3 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
IPI-145 is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. |
Get all suppliers by the below link:
Duvelisib (IPI-145, INK1197) suppliers
| 2024-07-15 |
Duvelisib(IPI-145,INK1197)
Price: Inquiry |
| 2020-01-06 |
Duvelisib (IPI-145, INK1197)
Price: $400.0 |
| 2025-09-17 |
Duvelisib (IPI-145, INK1197)
Price: ¥Inquiry |
| 2023-08-31 |
Duvelisib
Price: ¥Inquiry |
| 2018-02-06 |
IPI-145
Price: ¥Inquiry |
| 2023-08-30 |
IPI-145
Price: ¥Inquiry |
| 2018-04-16 |
INK1197
Price: ¥Inquiry |
| 2021-05-10 |
IPI-145
Price: ¥Inquiry |
| 2020-12-08 |
Duvelisib
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


